BDI Pharma Awarded Three-Year Consignment Contract with National GPO Premier, Inc.
BDIVantage Plus Consignment Program now offered to members of acute care GPO, Premier, Inc.
COLUMBIA, S.C., Feb. 25, 2015 /PRNewswire/ -- Specialty pharmaceutical distributor BDI Pharma, Inc. announced today that it was awarded the contract to offer GPO compliant consignment services to acute care members of Premier, Inc. through its industry renowned program, BDIVantage Plus. The contract is in effect January 1, 2015 through December 31, 2017.
Photo - http://photos.prnewswire.com/prnh/20150224/177444LOGO
"This is a wonderful opportunity for BDI to provide a financially viable option for consignment to members of Premier," states Chris Dillon, CCO of BDI Pharma. "We look forward to running a mutually beneficial program for the facilities while offering all of the benefits and conveniences of working with BDI Pharma."
BDI's consignment program has been a mainstay among their acute care customers for over fifteen years. With one of the simplest structures on the market for any consignment program, BDIVantage Plus is a cost effective solution for inventory management of specialty pharmaceuticals. For more information about utilizing BDIVantage Plus (Premier Contracted Supplier Number PPPW17BDI01), please call 1-800-948-9834.
About BDI Pharma, Inc.
BDI Pharma creates customized solutions to meet the distribution and support needs of manufacturers, healthcare providers, and patients throughout the life of each product within the specialty, niche pharmaceutical market. We aspire towards financial viability for all parties involved, employing a partnership oriented approach to drive value for our customers. While continuously refining the concept of niche distribution to provide solutions beyond the traditional wholesaler model, we operate as an extension of our partners' sales force. This approach of serving the manufactures as well as healthcare providers and patients over the last two decades has proven successful regardless of varying market conditions.
The company's website www.bdipharma.com serves as an invaluable resource for reference material, educational literature and online ordering. Proprietary programs offering comprehensive reimbursement services - www.bdiaccess.com and 855-BDI-CARE; and product consignment - www.bdivantageplus.com; are just a few of the many solutions tailored to the needs of the entire healthcare community. BDI Pharma's product portfolio includes IVIG, branded and generic specialty pharmaceuticals, chemotherapy, vaccines, albumin, coagulation factors, high-titer or "hyper" immune globulins, and other niche, specialty products. BDI Pharma is recognized as an "ADR," or Authorized Distributor of Record, for all of the manufacturers it represents.
Contact: Brad Davis
800-948-9834
Email
SOURCE BDI Pharma, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article